Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,042,688
+$307,422 QoQ
Shares Held
14,510
+133.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#635
of 1,414 holders
Holding Since
Dec 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Derivatives in ZTS
reported options exposure · as of Mar 31, 2024CallValue
$0
CallShares
0
PutValue
$338,420
PutShares
2,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CSS LLC/IL holds $5,738,432 across 10 Drug Manufacturers - Specialty & Generic names. ZTS ranks #3 (18.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
31,338 | $1,086,488 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
6,350 | $1,070,229 | |
| 3 | ZTS |
Zoetis Inc.
This page
|
14,510 | $1,042,688 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
1,892 | $1,025,142 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
27,070 | $917,131 | |
| 6 | TRLV |
Trulieve Cannabis Corp.
|
29,875 | $293,671 | |
| 7 | VTRS |
Viatris Inc
|
11,120 | $176,585 | |
| 8 | YCBD |
cbdMD, Inc.
|
137,621 | $92,618 |
All Filings in ZTS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,042,688 | 14,510 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $735,266 | 6,220 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $703,333 | 5,590 | Shares | Sole | 2026-02-17 | |
| 2024-03-31 | $338,420 | 2,000 | Put | Sole | 2024-05-15 | |
| 2023-12-31 | $986,850 | 5,000 | Put | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||